Updated Epidemiology of Gastrointestinal Cancers in the Asia‐Pacific: Evidence From GBD 2021 and GLOBOCAN 2022
Journal of Gastroenterology and Hepatology · 2026-06 · 41 (6) · 1670-1684
DOI: 10.1111/jgh.70404 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 25.04.2026. Verfasst von Primrose Tothanarungroj und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben.
Abstract (Originalsprache)
Gastrointestinal (GI) cancer poses a significant burden in the Asia‐Pacific region. Growing and aging populations, cancer prevention efforts, and treatment advances have all influenced GI cancer trends. This review provides an updated overview of GI cancer epidemiology in the region, using age‐standardized incidence rates (ASIRs) and death rates (ASDRs) from the Global Burden of Disease 2021 and the Global Cancer Observatory 2022. Differences between the two datasets should be interpreted with consideration of variations in methodology, standard populations, and reporting years. Colorectal cancer ranks highest in all regions across both datasets for ASIR. However, ASDR is less uniform. There is geographic heterogeneity in GI cancer burden, with Mongolia disproportionately impacted by esophageal, gastric, and liver cancers, while Japan and Australia have a considerable burden of colorectal and pancreatic cancers, along with gastric cancer in Japan. Lower mortality‐to‐incidence ratios for colorectal and gastric cancers may reflect the effective implementation of screening programs, facilitating early detection and effective treatments. Conversely, esophageal, pancreatic, and gallbladder cancers have lower ASIRs but incidence‐to‐mortality ratio near one, likely reflecting lack of cost‐effective screening and poor prognosis with late‐stage diagnoses. Several South‐East Asian and Pacific Island countries with lower socioeconomic status show markedly lower ASIRs and ASDRs, which may reflect differences in data availability, reporting, and healthcare access, highlighting the need to strengthen national cancer registry systems. Altogether, this review offers up‐to‐date GI cancer epidemiology insights to support healthcare providers and policymakers in developing targeted strategies to reduce the burden of GI cancer in the Asia‐Pacific region.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
- Immunology Unit, Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
- Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, Arizona, USA.
- Department of Internal Medicine, Banner University Medical Center, Phoenix, Arizona, USA.
- BIO5 Institute, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.
ORCID-Profile: Primrose Tothanarungroj, Pojsakorn Danpanichkul, Ju Dong Yang, Amit G Singal
Zitieren
APA
Tothanarungroj, P., Suparan, K., Danpanichkul, P., Wijarnpreecha, K., Yang, J. D., & Singal, A. G. (2026). Updated Epidemiology of Gastrointestinal Cancers in the Asia‐Pacific: Evidence From GBD 2021 and GLOBOCAN 2022. Journal of Gastroenterology and Hepatology, 41(6), 1670-1684. https://doi.org/10.1111/jgh.70404
Vancouver
Tothanarungroj P, Suparan K, Danpanichkul P, Wijarnpreecha K, Yang JD, Singal AG. Updated Epidemiology of Gastrointestinal Cancers in the Asia‐Pacific: Evidence From GBD 2021 and GLOBOCAN 2022. Journal of Gastroenterology and Hepatology. 2026;41(6):1670-1684. doi:10.1111/jgh.70404
BibTeX
@article{Tothanarungroj2026,
author = {Tothanarungroj, Primrose and Suparan, Kanokphong and Danpanichkul, Pojsakorn and Wijarnpreecha, Karn and Yang, Ju Dong and Singal, Amit G},
title = {Updated Epidemiology of Gastrointestinal Cancers in the Asia‐Pacific: Evidence From GBD 2021 and GLOBOCAN 2022},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {41},
number = {6},
pages = {1670--1684},
doi = {10.1111/jgh.70404}
}
EUVIMED